Stroke disease management--a framework for comprehensive stroke care

Disease management is an approach to patient care that coordinates medical resources for the patient across the entire healthcare delivery system throughout the lifetime of the patient with the disease. Stroke is suitable for disease management as it is a well-known disease with a high prevalence, high cost, variable practice pattern, poor clinical outcome, and managed by a non-integrated healthcare system. It has measurable and actionable outcomes, with available local expertise and support of the Ministry of Health. Developing the programme requires a multidisciplinary team, baseline data on target populations and healthcare services, identification of core components, collaboration with key stakeholders, development of evidence-based clinical practice guidelines and carepaths, institution of care coordinators, use of information technology and continuous quality improvement to produce an effective plan. Core components include public education, risk factor screening and management, primary care and specialist clinics, acute stroke units, inpatient and outpatient rehabilitation facilities, and supportive community services including medical, nursing, therapy, home help and support groups for patients and carers. The family physician plays a key role. Coordination of services is best done by a network of hospital and community-based care managers, and is enhanced by a coordinating call centre. Continuous quality improvement is required, with audit of processes and outcomes, facilitated by a disease registry. Pitfalls include inappropriate exclusion of deserving patients, misuse, loss of physician and patient independence, over-estimation of benefits, and care fragmentation. Collaboration and cooperative among all parties will help ensure a successful and sustainable programme.

Consumer satisfaction with OTC drugs: an analysis using the confirmation/disconfirmation model

This study explored the determinants of consumer satisfaction with OTC drugs using the confirmation/disconfirmation model. A revised confirmation/disconfirmation model specifically for OTC drugs was proposed and tested using structural equation modeling with a specific product category: cold medications. The results of this study found that the confirmation/disconfirmation of a consumer's expectation and perceived performance of an OTC drug is important in predicting consumer satisfaction. Theoretical and managerial implications for pharmaceutical marketers are discussed.

Electrochemical evaluation of electron acceptor materials

The electrochemical half-wave reduction potential (E1/2) of 33 electron acceptor molecules in dry methylene chloride has been measured by cyclic voltammetry (CV) at a mercury electrode. The differences in E1/2 values for the reversible reduction to the corresponding anion radicals reflect the electronic influence of the substituent at different ring positions.The measurements of the half-wave reduction potentials provided a convenient method for determining the conducting energy levels of the electron relay molecules in condensed media. Repetitive potential cycle measurements provided information on the chemical stability and cyclability of the intermediate anion radicals formed during electron transport processes.